Analytical Services
Precision Analytical Services for Pharmaceutical Development
At PI Health Sciences, our pharmaceutical analytical services deliver comprehensive bioanalytical and pharmaceutical analytical support across the full drug development lifecycle. From preclinical research through commercial programs, we generate high quality, submission ready data through scientifically rigorous and regulatory aligned execution. Our integrated approach combines advanced instrumentation, domain expertise, and structured analytical governance to ensure accuracy, reproducibility, and compliance.
Our analytical framework is built around phase specific solutions, ensuring that methods are tailored to development stage requirements. We provide method development, method validation, quality control testing, and stability studies within a unified operational model. Equipped with 21 CFR Part 11 compliant systems, our laboratories maintain data integrity and global regulatory alignment throughout execution.
Through transparent collaboration and regulatory focused delivery, PI Health Sciences partners with pharmaceutical and biotech organizations to reduce development risk, accelerate timelines, and support successful IND, NDA, and ANDA submissions.
Capabilities
Phase Appropriate Analytical Strategy & Method Lifecycle Management
We design customized analytical methods aligned to preclinical, clinical, and commercial requirements. Our services include structured method development, method validation, transfer, and lifecycle management to ensure reproducibility and regulatory acceptance. Phase specific analytical planning supports seamless progression from early development to market authorization.
Comprehensive Pharmaceutical & Bioanalytical Services
Our integrated model encompasses method development, validation, quality control testing, and stability studies under one coordinated framework. Structural identification, impurity characterization, and stability testing strengthen product understanding and regulatory documentation. Analytical execution is aligned to support complex pharmaceutical development programs.
Advanced Instrumentation & Data Integrity Systems
All analytical operations are supported by advanced instrumentation operating under 21 CFR Part 11 compliant systems. Digital controls and secure data environments ensure traceability, accuracy, and regulatory readiness. Structured documentation practices reinforce data reliability across global submissions.
Regulatory & Quality Governance Framework
Our pharmaceutical analytical services are built around compliance with ICH, USFDA, USP, and Ph. Eur standards. Cross functional expertise from analytical chemists, quality specialists, and regulatory professionals ensures that data packages meet global expectations. Analytical workflows are aligned to support IND, NDA, and ANDA regulatory pathways.
Innovation Driven Analytical Excellence
We leverage AI powered tools and advanced analytics to generate data driven insights throughout the drug development lifecycle. Custom analytical strategies address complex product challenges while maintaining scientific rigor and regulatory discipline. Continuous innovation ensures reliable, defensible, and high quality analytical outcomes.
Frequently asked questions
We’re here to help with any questions you have about our plans, supported features, and how our model works.
What stages of development do our pharmaceutical analytical services support?
Our pharmaceutical analytical services support the full drug development lifecycle, spanning preclinical, clinical, and commercial phases. We design phase specific analytical strategies that align with evolving regulatory and technical requirements at each milestone. From early method development and feasibility assessments to validated methods supporting commercialization, our structured lifecycle management ensures continuity, reproducibility, and submission readiness across all stages of development.
Are our analytical systems compliant with regulatory standards?
Our analytical laboratories operate using 21 CFR Part 11 compliant systems to ensure data integrity, traceability, and secure electronic record management. All pharmaceutical analytical services are executed in accordance with global regulatory expectations, including ICH, USFDA, USP, and Ph. Eur standards. This compliance driven framework ensures that analytical outputs are suitable for global regulatory submissions and withstand inspection scrutiny.
What types of analytical capabilities do we offer?
We provide comprehensive pharmaceutical and bioanalytical services, including method development, method validation, quality control testing, and stability studies. Our capabilities extend to structural identification, impurity characterization, and scientifically structured stability programs. These services are delivered within an integrated analytical model that supports robust product understanding and regulatory documentation throughout development.
How do our services support regulatory submissions?
Our analytical solutions are aligned with regulatory pathways such as IND, NDA, and ANDA submissions. We generate submission ready data packages supported by validated methodologies, structured documentation, and regulatory compliant data systems. By integrating regulatory considerations early in method development and validation, we minimize submission risks and support efficient review processes.
How does PI Health Sciences ensure quality and consistency in analytical execution?
Quality and consistency are maintained through standardized method lifecycle management, advanced instrumentation, and regulatory governed analytical workflows. Cross functional collaboration between analytical chemists, quality professionals, and regulatory specialists ensures that all testing activities meet global compliance standards. Digital systems and structured documentation practices further reinforce reproducibility, traceability, and audit readiness.
Contact Us
Connect with PI Health Sciences to leverage high-precision analytical capabilities that ensure data integrity, regulatory alignment, and confident progression of your therapeutic candidates across discovery and preclinical development.